Work

NAD in pathological cardiac remodeling: Metabolic regulation and beyond

Year: 2024

Type: article

Source: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

DOI: 10.1016/j.bbadis.2024.167038

Authors: Ignacio Norambuena-Soto, Yingfeng Deng, Charles Brenner, Sergio Lavandero, Zhao V. Wang

Institutions: City Of Hope National Medical Center, Advanced Center for Chronic Diseases, Beckman Research Institute, University of Chile, The University of Texas Southwestern Medical Center

Language: English

Topic: Sirtuins and Resveratrol in Medicine

Subfield: Geriatrics and Gerontology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: American Diabetes Association, American Heart Association, Agencia Nacional de Investigación y Desarrollo, Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación, National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, Fondo Nacional de Desarrollo Científico y Tecnológico, Fondo de Financiamiento de Centros de Investigación en Áreas Prioritarias

Awards: G2242824277, G2679863027, G3002049137, G3654142842, Evaluating NAD Supplementation as a Novel Treatment for Arrhythmias, G571589808, ROLE OF MUL1 IN THE SEX-SPECIFIC DEVELOPMENT OF HIGH FAT DIET-INDUCED CARDIAC DYSFUNCTION, G652983587, Novel mechanisms of cardio-metabolic disease: Role of inter-organ crosstalk, G7810589229, G8417900696, CENTRO DE ESTUDIOS AVANZADOS DE ENFERMEDADES CRONICAS (ACCDIS), G8560798181, G8561051367, EVALUACION DEL EFECTO FARMACOLOGICO DE ANGIOTENSINA-(1-9) SOBRE LA DESENSIBILIZACION A INSULINA EN EL CORAZON INDUCIDA POR DIETA ALTA EN GRASA, G8794338893, UT Southwestern NORC, Chimeric RNA in pathological cardiac remodeling, G99091514

OpenAlex ID: W4391281022

FWCI: 1.82

Cites: 142

Cited by: 8

Related to: 10